Apolipoprotein C-III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria.

Fanny Jansson SigfridsLars StechemesserErika B Parente Carol M Forsblom Joanne B ColeRaimund WeitgasserMarja-Riitta Taskinen Per-Henrik Groopnull null

Published in: Journal of internal medicine (2021)

The impact of apoC-III on MACE risk and mortality is restricted to those with albuminuria among individuals with type 1 diabetes. This study also revealed that apoC-III predicts DKD progression, independent of the initial DKD category.

Keyphrases

cardiovascular events
coronary artery disease
cardiovascular disease
type diabetes
risk factors